Agilent brings enhanced solutions for biotherapeutics
Agilent Technologies has announced the new Agilent 6560C Ion Mobility LC/Q-TOF, enhancements to the VWorks automation software suite, and new AssayMAP large capacity cartridges. The products improve the analysis of proteins and peptides to speed up the development of new proteinbased therapeutics in biopharma. The new Agilent products address specific stages of the development workflow, from sample preparation to secure protocols, and software to complex protein structural analysis.
The 6560C Ion Mobility Q-TOF adds new capabilities that enhance flexibility and performance over its predecessors for more precise measurements of large protein complexes such as biotherapeutic antibodies and large protein assemblies. VWorks 14.1 offers seamless adoption of automation and the Bravo platform into regulated environments to improve sample throughput, enhance reproducibility and reduce errors. The AssayMAP large capacity cartridges extend the portfolio of available chemistries with the introduction of Protein A affinity purification cartridges and reversed-phase cartridges for antibody enrichment and peptide cleanup, respectively. The products enable automated sample preparation upstream of multiple critical quality analyses across the biotherapeutic development process.